BlackRock’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
9,945,448
+1,720,304
| +21% | +$3.6M | ﹤0.01% | 2955 |
|
|
2025
Q1 | $14M | Buy |
8,225,144
+177,559
| +2% | +$303K | ﹤0.01% | 3102 |
|
|
2024
Q4 | $40.6M | Buy |
8,047,585
+508,246
| +7% | +$2.57M | ﹤0.01% | 2552 |
|
|
2024
Q3 | $41M | Buy |
7,539,339
+399,325
| +6% | +$2.17M | ﹤0.01% | 2560 |
|
|
2024
Q2 | $34.3M | Buy |
7,140,014
+2,351,274
| +49% | +$11.3M | ﹤0.01% | 2615 |
|
|
2024
Q1 | $14.9M | Sell |
4,788,740
-110,549
| -2% | -$344K | ﹤0.01% | 3094 |
|
|
2023
Q4 | $13.9M | Buy |
4,899,289
+398,803
| +9% | +$1.13M | ﹤0.01% | 3155 |
|
|
2023
Q3 | $13.2M | Buy |
4,500,486
+195,981
| +5% | +$574K | ﹤0.01% | 3115 |
|
|
2023
Q2 | $12.3M | Buy |
4,304,505
+501,265
| +13% | +$1.43M | ﹤0.01% | 3246 |
|
|
2023
Q1 | $11.8M | Sell |
3,803,240
-207,162
| -5% | -$640K | ﹤0.01% | 3164 |
|
|
2022
Q4 | $8.46M | Buy |
4,010,402
+1,799,047
| +81% | +$3.8M | ﹤0.01% | 3408 |
|
|
2022
Q3 | $7.21M | Sell |
2,211,355
-185,023
| -8% | -$603K | ﹤0.01% | 3524 |
|
|
2022
Q2 | $7.69M | Buy |
2,396,378
+818,459
| +52% | +$2.63M | ﹤0.01% | 3556 |
|
|
2022
Q1 | $11.1M | Buy |
1,577,919
+176,846
| +13% | +$1.25M | ﹤0.01% | 3443 |
|
|
2021
Q4 | $10.2M | Buy |
+1,401,073
| New | +$10.2M | ﹤0.01% | 3601 |
|